- Pfizer Inc (NYSE:PFE) will acquire Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN) for $148.50 per share, equivalent to $11.6 billion.
- Pfizer will also make payments at closing to settle Biohaven's third-party debt and for the redemption of all outstanding shares of Biohaven's redeemable preferred stock.
- The deal includes the acquisition of rimegepant (NURTEC ODT), a dual-acting migraine therapy approved for acute treatment and episodic prevention of migraine in adults, Zavegepant, and a portfolio of five pre-clinical CGRP assets.
- Biohaven reported Q1 product revenue of $123.6 million, up 182%, due to increased NURTEC ODT sales volume and improvements in net price realization.
- EPS loss came in at $(1.62), down from $(3.25) a year ago
- It expects FY22 product sales of $825 - $900 million.
- BHVN closed Q1 with a cash balance of $602.5 million.
- Related: Biohaven Further Deepens Its Neurology Pipeline With Bristol Myers, Knopp Biosciences Deals.
- Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven's non-CGRP development stage pipeline compounds, per Biohaven common share.
- This agreement follows the collaboration for the commercialization of rimegepant and zavegepant outside the U.S. Pfizer invested $350 million to acquire 2.6% of Biohaven's common stock at $173 per share.
- Price Action: BHVN shares are up 74.4% at $144.98 during the premarket session on the last check Tuesday.
- Photo by Capri23auto from Pixabay
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
Pfizer Acquires This Migraine Drug Maker For $11B: What Investors Need To Know
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks